# Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)

> **NCT03430869** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 59 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** F-18 AV-45
- **DRUG:** F-18-THK-5351

## Key facts

- **NCT ID:** NCT03430869
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-23
- **Primary completion:** 2021-12-28
- **Final completion:** 2021-12-31
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430869, "Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03430869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*